The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1

Authors

Bimmi Shrestha, Washington University School of Medicine in St. Louis
James D. Brien, Washington University School of Medicine in St. Louis
Soila Sukupolvi-Petty, Washington University School of Medicine in St. Louis
S. Kyle Austin, Washington University School of Medicine in St. LouisFollow
Melissa A. Edeling, Washington University School of Medicine in St. Louis
Taekyung Kim, Washington University School of Medicine in St. Louis
Katie M. O'Brien, Washington University School of Medicine in St. Louis
Christopher A. Nelson, Washington University School of Medicine in St. Louis
Syd Johnson, MacroGenics, Inc., Rockville, Maryland
Daved H. Fremont, Washington University School of Medicine in St. LouisFollow
Michael S. Diamond, Washington University School of Medicine in St. LouisFollow

Journal

PLoS Pathogens

Publication Date

2010

Volume

6

Issue

4

Inclusive Pages

e1000823

Document Type

Open Access Publication

DOI

10.1371/journal.ppat.1000823

Rights and Permissions

Shrestha B, Brien JD, Sukupolvi-Petty S, Austin SK, Edeling MA, et al. 2010 The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1. PLoS Pathog 6(4): e1000823. doi:10.1371/journal.ppat.1000823

Recommended Citation

Shrestha, Bimmi; Brien, James D.; Sukupolvi-Petty, Soila; Austin, S. Kyle; Edeling, Melissa A.; Kim, Taekyung; O'Brien, Katie M.; Nelson, Christopher A.; Johnson, Syd; Fremont, Daved H.; and Diamond, Michael S., "The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1." PLoS Pathogens. 6, 4. e1000823. (2010).
https://digitalcommons.wustl.edu/open_access_pubs/659